Tags
Results for: Hourigan Lab
-
Article ItemImmunotherapy for leukemia may change the bone marrow environment, cancer researchers find , article
Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia have found that a type of treatment — immunotherapy — may help change the environment where cancer cells live, possibly helping the immune system respond more effectively.
Date: Jul 31, 2025 - -
Video ItemCancer Researchers Spurred to Move Faster at the Cancer Research Symposium , video
For every careful step forward in cancer research, there is a patient waiting — a family holding its breath in the middle of the night. That reality was clear at the Fralin Biomedical Research Institute’s Cancer Research Symposium in Roanoke. The annual event, organized this year by the Fralin Biomedical Research Institute at VTC Cancer Research Center in Roanoke, was created to bring together researchers — including faculty, clinicians, and students — who are united by a passion to understand cancer, improve treatments, and develop cures.
Date: Jun 25, 2025 - -
Article ItemGraduate students share work at inaugural research showcase at Academic Building One , article
Graduate students from programs across the greater Washington, D.C,. metro area shared their work at the Graduate Education Week Research Showcase in Alexandria.
Date: Apr 03, 2025 - -
Article ItemNew Virginia Tech cancer researcher seeks to understand and predict deadly tumor metastasis , article
Shenglin Mei, the newest principal investigator of the Fralin Biomedical Research Institute Cancer Research Center in Washington, D.C., applies computational biology, genetics, and immunology to study cancer’s spread away from the primary tumor.
Date: Dec 17, 2024 - -
Article ItemVirginia Tech, Children’s National Hospital, and industry experts explore the impact of AI on health care , article
While exploring the potential of artificial intelligence, old fashioned networking and human relationships held the floor.
Date: Sep 24, 2024 - -
Article ItemFederal leaders take center stage at Engineering Cancer Solutions mini-symposium , article
Three federal leaders – one each from the White House, the National Cancer Institute, and the Food and Drug Administration – mixed with Virginia Tech students, early career researchers, and leadership at the Fralin Biomedical Research Institute Cancer Research Center in Washington, D.C.
Date: Jul 12, 2024 - -
Article ItemTesting for residual cancer cells before blood cell transplant therapy is important and practical, new study finds , article
Patients in remission after battling blood cancer are likely to have better outcomes if no trace of the cancer is detectable before the patients receive donor blood cells. The finding in JAMA Oncology emphasizes the importance of testing for lingering cancer cells in the body after people receive apparently successful chemotherapy treatment.
Date: May 02, 2024 - -
Video ItemEminent cancer physician-scientist joins Virginia Tech to lead research in Washington, D.C. , video
Christopher Hourigan will spearhead innovative cancer solutions at the Fralin Biomedical Research Institute Cancer Research Center in the nation's capital.
Date: Apr 10, 2024 - -
Article ItemVirginia Tech professor to be inducted into prestigious American Society for Clinical Investigation , article
Christopher Hourigan, director of the Cancer Research Center – D.C., has been inducted into the American Society for Clinical Investigation, a historic membership for a faculty member of Virginia Tech.
Date: Apr 04, 2024 - -
Article ItemEminent cancer physician-scientist joins Virginia Tech to lead research in Washington, D.C. , article
A National Institutes of Health senior investigator who studies and treats blood cancer, Christopher Hourigan is joining Virginia Tech to lead cancer research at the Fralin Biomedical Research Institute in Washington, D.C.
Date: Apr 01, 2024 -